PMID- 34884933 OWN - NLM STAT- MEDLINE DCOM- 20220107 LR - 20220107 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 22 IP - 23 DP - 2021 Dec 4 TI - Prenatal Exposure to Triclocarban Impairs ESR1 Signaling and Disrupts Epigenetic Status in Sex-Specific Ways as Well as Dysregulates the Expression of Neurogenesis- and Neurotransmitter-Related Genes in the Postnatal Mouse Brain. LID - 10.3390/ijms222313121 [doi] LID - 13121 AB - Triclocarban is a highly effective and broadly used antimicrobial agent. Humans are continually exposed to triclocarban, but the safety of prenatal exposure to triclocarban in the context of neurodevelopment remains unknown. In this study, we demonstrated for the first time that mice that had been prenatally exposed to environmentally relevant doses of triclocarban had impaired estrogen receptor 1 (ESR1) signaling in the brain. These mice displayed decreased mRNA and protein expression levels of ESR1 as well as hypermethylation of the Esr1 gene in the cerebral cortex. Prenatal exposure to triclocarban also diminished the mRNA expression of Esr2, Gper1, Ahr, Arnt, Cyp19a1, Cyp1a1, and Atg7, and the protein levels of CAR, ARNT, and MAP1LC3AB in female brains and decreased the protein levels of BCL2, ARNT, and MAP1LC3AB in male brains. In addition, exposure to triclocarban caused sex-specific alterations in the methylation levels of global DNA and estrogen receptor genes. Microarray and enrichment analyses showed that, in males, triclocarban dysregulated mainly neurogenesis-related genes, whereas, in females, the compound dysregulated mainly neurotransmitter-related genes. In conclusion, our data identified triclocarban as a neurodevelopmental risk factor that particularly targets ESR1, affects apoptosis and autophagy, and in sex-specific ways disrupts the epigenetic status of brain tissue and dysregulates the postnatal expression of neurogenesis- and neurotransmitter-related genes. FAU - Wnuk, Agnieszka AU - Wnuk A AUID- ORCID: 0000-0003-3620-3902 AD - Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland. FAU - Rzemieniec, Joanna AU - Rzemieniec J AUID- ORCID: 0000-0002-5732-2794 AD - Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland. FAU - Przepiorska, Karolina AU - Przepiorska K AD - Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland. FAU - Pietrzak, Bernadeta Angelika AU - Pietrzak BA AD - Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland. FAU - Mackowiak, Marzena AU - Mackowiak M AUID- ORCID: 0000-0002-6056-9595 AD - Laboratory of Pharmacology and Brain Biostructure, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland. FAU - Kajta, Malgorzata AU - Kajta M AD - Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland. LA - eng GR - 2015/19/B/NZ7/02449/National Science Center/ GR - N/A/the statutory fund of the Maj Institute of Pharmacology at the Polish Academy of Sciences in Krakow, Poland/ PT - Journal Article DEP - 20211204 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Anti-Infective Agents, Local) RN - 0 (Carbanilides) RN - 0 (Esr1 protein, mouse) RN - 0 (Estrogen Receptor alpha) RN - 0 (Neurotransmitter Agents) RN - BGG1Y1ED0Y (triclocarban) SB - IM MH - Animals MH - Anti-Infective Agents, Local/toxicity MH - Blood-Brain Barrier/drug effects MH - Brain/*drug effects MH - Carbanilides/*toxicity MH - DNA Methylation/drug effects MH - Epigenesis, Genetic/drug effects MH - Estrogen Receptor alpha/*metabolism MH - Female MH - Gene Expression Regulation/drug effects MH - Male MH - Mice MH - Neurogenesis/*drug effects/genetics MH - Neurotransmitter Agents/genetics/metabolism MH - Pregnancy MH - *Prenatal Exposure Delayed Effects MH - Sex Factors MH - Signal Transduction/drug effects PMC - PMC8658534 OTO - NOTNLM OT - DNA methylation OT - environmentally pervasive chemicals OT - estrogen receptors OT - microarrays OT - xenobiotic receptors COIS- The authors declare that they have no actual or potential conflicts of interest, including any financial, personal, or other relationships that could inappropriately influence or be perceived to influence the submitted work. EDAT- 2021/12/11 06:00 MHDA- 2022/01/08 06:00 PMCR- 2021/12/04 CRDT- 2021/12/10 01:05 PHST- 2021/10/19 00:00 [received] PHST- 2021/11/30 00:00 [revised] PHST- 2021/12/01 00:00 [accepted] PHST- 2021/12/10 01:05 [entrez] PHST- 2021/12/11 06:00 [pubmed] PHST- 2022/01/08 06:00 [medline] PHST- 2021/12/04 00:00 [pmc-release] AID - ijms222313121 [pii] AID - ijms-22-13121 [pii] AID - 10.3390/ijms222313121 [doi] PST - epublish SO - Int J Mol Sci. 2021 Dec 4;22(23):13121. doi: 10.3390/ijms222313121.